The interleukin 4 receptor (IL-4R) is a central mediator of T helper type 2 (T H 2)-mediated disease and associates with either the common c-chain to form the type I IL-4R or with the IL-13R a1 chain (IL-13Ra1) to form the type II IL-4R. Here we used Il13ra1 -/-mice to characterize the distinct functions of type I and type II IL-4 receptors in vivo. In contrast to Il4ra -/-mice, which have weak T H 2 responses, Il13ra1 -/-mice had exacerbated T H 2 responses. Il13ra1 -/-mice showed much less mortality after infection with Schistosoma mansoni and much more susceptibility to Nippostrongylus brasiliensis. IL-13Ra1 was essential for allergen-induced airway hyperreactivity and mucus hypersecretion but not for fibroblast or alternative macrophage activation. Thus, type I and II IL-4 receptors exert distinct effects on immune responses.
Interleukin 4 (IL-4) and IL-13 are T helper type 2 (T H 2) cytokines with pleiotropic functions in immunity. They mediate resistance to many gastrointestinal parasites 1 and promote allergic inflammation 2, 3 , asthma 4 and fibrosis 5 . IL-4 and IL-13 exert a wide range of effects on many cell types, including macrophages, fibroblasts, eosinophils, mast cells, natural killer cells, B cells and T cells 6 . IL-4 and IL-13 bind to and send signals through receptors composed of various combinations of four receptor subunits: IL-4Ra, IL-13Ra1, IL-13Ra2 and the common g-chain. The type I IL-4 receptor, a heterodimer of IL-4Ra and the common g-chain, mediates IL-4-dependent activation of the transcription factor STAT6 in hematopoietic cells and is thus mostly responsible for the population expansion of CD4 + T H 2 cells. The type II IL-4 receptor, a heterodimer of IL-4Ra and IL-13Ra1 chains, can bind both IL-4 and IL-13 and is thought to be the main route by which nonhematopoietic cells respond to these cytokines 7 . Finally, the IL-13Ra2 chain binds IL-13 with high affinity and functions as a 'decoy receptor' 8 , although a report has suggested it can also show STAT6-independent signaling activity 9 .
Because IL-4Ra functions as subunit of receptors binding both IL-4 and IL-13, it is the most widely studied of the four receptor subunits. However, although it is now apparent that IL-4Ra is central to the pathogenesis of a wide variety of T H 2-associated diseases, thus far it has been impossible to assign the various functions of IL-4Ra to the type I or type II IL-4R signaling pathway, because both receptor complexes are absent from IL-4Ra-deficient mice. Therefore, to elucidate the physiological function of the type II receptor, we generated mice with targeted deletion of Il13ra1. We used in vitro studies to assess the function of the type II IL-4R in the development of alternatively activated macrophages (AAMfs) and in the activation of fibroblasts. Our in vivo studies focused on the function of the type II IL-4R after infection with the T H 2-inducing pathogens Schistosoma mansoni and Nippostrongylus brasiliensis and in an experimental model of asthma. We found that in contrast to IL-4Ra, IL-13Ra1 was not required for AAMf development. Il13ra1 -/-mice also developed stronger CD4 + T H 2 responses. However, Il13ra1 -/-mice showed less morbidity and mortality after S. mansoni infection and failed to expel N. brasiliensis from the gut. In addition, airway hyperreactivity and mucus production were completely abrogated after intratracheal administration of a T H 2-inducing allergen in Il13ra1 -/-mice. Thus, our studies elucidate the unique functions of the type I and type II IL-4R signaling pathways in the development of T H 2 immune responses.
RESULTS

Generation of Il13ra1 -/-mice
We used VelociGene technology 10 to create a targeting vector in which exon 2 (except for its first 17 nucleotides) through exon 4 were replaced with the transmembrane lacZ reporter gene and a loxP-flanked neomycin selection cassette ( Supplementary Fig. 1a online). We assigned scores for correct gene targeting in F 1 H 4 (C57BL/6 Â 129 hybrid) embryonic stem cell clones by the loss-ofnative-allele assay 10 and determined the genotypes of Il13ra1 +/+ , Il13ra1 +/-and Il13ra1 -/-offspring by PCR analysis ( Supplementary  Fig. 1b ). Il13ra1 -/-mice were healthy and fertile and manifested no physical impairment. Naive Il13ra1 -/-mice showed no fundamental anomalies in the lymphoid compartment; thymi, lymph nodes and spleens were of a size and cellularity similar to that of their Il13ra1 +/+ littermates (Supplementary Table 1 online). CD4 + , CD8 + and CD4 + CD8 + populations were present at the expected frequencies in the thymus (Fig. 1) . B cells, CD4 + and CD8 + T cells, and natural killer cells were also present in wild-type proportions and numbers in the spleen and lymph nodes.
IL-13Ra1 in macrophage and fibroblast activation
Alternative macrophage activation is regulated by an IL-4Ra-STAT6-dependent mechanism 11 ; however, the function of type I versus type II IL-4R signaling in the development of classically and alternatively activated macrophages has remained unclear. To elucidate the contribution of the type II IL-4R, we generated bone marrow-derived macrophages (BMDMs) from Il13ra1 +/+ and Il13ra1 -/-mice. We then examined the ability of IL-4 and IL-13 to regulate a variety of responses, including phosphorylation of STAT6, expression of STAT6-regulated genes (Chi3l3 and Arg1), elaboration of arginase activity, and interferon-g (IFN-g)-induced nitric oxide production.
As expected, both IL-4 and IL-13 stimulated STAT6 phosphorylation in Il13ra1 +/+ BMDMs (Fig. 2a) . In contrast, IL-4 but not IL-13 triggered STAT6 phosphorylation in Il13ra1 -/-BMDMs. Il13ra1 -/-mice showed no IL-13-induced increase in Chi3l3 or Arg1 mRNA (Fig. 2b) and, unlike Il13ra1 +/+ BMDMs, did not show substantial arginase activity after IL-13 simulation (Fig. 2c) . We obtained similar results with thioglycollate-elicited macrophages, although Il13ra1 +/+ thioglycollate-elicited macrophages showed greater arginase activity at baseline and after IL-13 stimulation than did Il13ra1 +/+ BMDMs (Fig. 2d) . Finally, IL-13 potently inhibited IFN-g-induced nitric oxide production (classical macrophage activation) in Il13ra1 +/+ macrophages but had no effect on nitric oxide production by Il13ra1 -/-macrophages, even at very high concentrations (Fig. 2e) . However, in contrast to IL-13, IL-4 exerted similar effects on Il13ra1 +/+ and Il13ra1 -/-macrophages.
IL-4 and IL-13 also regulate the function of nonhematopoietic mesenchymal cells, including fibroblasts 12 . Nevertheless, it has remained unclear whether IL-4 and IL-13 exploit mainly type I or type II IL-4R signaling pathways in fibroblast activation 7, 13, 14 . To address this, we generated primary fibroblasts from Il13ra1 +/+ and Il13ra1 -/-mice and monitored STAT6 phosphorylation and STAT6-dependent gene expression (Chi3l3, Retnla and Il13ra2) after stimulating the cells with IL-4 and IL-13. As expected, we found no detectable Il13ra1 message in Il13ra1 -/-fibroblasts. In contrast, transcripts encoding the common g-chain (Il2rg) and IL-4Ra were readily detectable in the mutant cells; Il13ra1 +/+ fibroblasts expressed transcripts encoding all three receptor subunits ( Supplementary Fig. 2a  online) . Expression of the common g-chain by nonhematopoietic cells, although unexpected, has been shown before in myofibroblasts 14 and human bronchial epithelial cells 15 . Consistent with those findings, there was IL-13-induced STAT6 phosphorylation in Il13ra1 +/+ but not Il13ra1 -/-fibroblasts ( Supplementary Fig. 2b ). The considerable increase in expression of Chi3l3, Retnla and Il13ra2 mRNA in IL-13-stimulated Il13ra1 +/+ fibroblasts was also abolished in Il13ra1 -/-fibroblasts, thus confirming the functional ablation of type II IL-4R signaling ( Supplementary Fig. 2c ). In contrast, IL-4 stimulated robust STAT6 phosphorylation and induction of Chi3l3 and Retnla mRNA in Il13ra1 +/+ and Il13ra1 -/-fibroblasts. Notably, we found consistently less IL-4-induced Il13ra2 mRNA expression in the Il13ra1 -/-fibroblasts, which suggested that at least a subset of IL-4-inducible genes depend on type II IL-4R signaling for optimal induction (Supplementary Fig. 2c) . In contrast to Il13ra2 expression, expression of genes encoding the other receptor subunits was not substantially regulated by IL-4 or IL-13 ( Supplementary Fig. 2d) . Thus, the type II IL-4R signaling pathway was functionally disabled in Il13ra1 -/-mice and was dispensable for fibroblast and alternative macrophage activation.
IL-13Ra1 in S. mansoni-induced T H 2 responses
In addition to modulating the activation of macrophages and fibroblasts, IL-4 and IL-13 regulate B cell proliferation and survival and antibody class switching 16, 17 . To elucidate the function of the type II IL-4R in B cells, we infected Il13ra1 +/+ and Il13ra1 -/-mice with S. mansoni and assessed the parasite-specific antibody response in acutely infected mice (8-9 weeks) and chronically infected mice (12 weeks). Unexpectedly, although IL-13 has been postulated to promote B cell survival and antibody class switching 18 , in general, the infected Il13ra1 +/+ and Il13ra1 -/-mice developed similar antibody responses (Fig. 3) . In fact, Il13ra1 -/-mice had more immunoglobulin A (IgA) at week 8 defect was restricted to chronically infected mice. Thus, type II IL-4R signaling is minimally involved in the development of humoral responses after infection with S. mansoni.
Although it is well known that IL-4 functions as the main inducer of CD4 + T H 2 cell responses, the function of IL-13 in the development of T H 2 responses is controversial 16, 19, 20 . Although IL-13 receptors are not expressed on T cells 21 , many studies with Il13 -/-mice have suggested that IL-13 has a critical albeit indirect function in the development of T H 2 cell-mediated responses in vivo 20 . However, disruptions in Il13 can affect expression of the closely linked Il4 gene, perhaps complicating the conclusions of such studies 19 . Because the type II IL-4R functions as the main signaling receptor for IL-13, Il13ra1 -/-mice provide an ideal tool for investigating the function of IL-13 and, more specifically, the contribution of type II IL-4R-mediated signaling in T H 2 responses in vivo.
We infected mice with S. mansoni cercariae and examined liver lymphocyte production of IL-4, IL-5, IL-13 and IFN-g ex vivo by intracellular cytokine staining at 9 and 12 weeks after infection. As expected, we detected many IL-4-, IL-5-and IL-13-producing CD4 + T cells in Il13ra1 +/+ livers at 9 weeks after infection (Fig. 4) . However, the percentage of T H 2 cytokine-producing CD4 + T cells was significantly higher in Il13ra1 -/-livers at both the acute and chronic time points. These data suggest that IL-13Ra1 exerts a negative effect on T H 2 response development in vivo, in contrast to its T H 2-skewing effect on neonatal CD4 + cells 22 . Notably, we found no change in the number of IFN-g-producing CD4 + T cells at week 9 and a small but consistent increase at week 12 in Il13ra1 -/-mice (Fig. 4) . Thus, the greater frequency of CD4 + T H 2 cells did not result from a diminished counter-regulatory T H 1 response. These data were reproducible on both the BALB/c and C57BL/6 genetic backgrounds (data not shown).
IL-13Ra1 in schistosomiasis
Next we examined the granulomatous response in the liver at 9 and 12 weeks after infection. In general, we noted no considerable differences in granuloma development in the Il13ra1 +/+ and Il13ra1 -/-mice at any time point, suggesting that type II IL-4R signaling has little effect on the overall inflammatory response (Fig. 5a ). However, we noted a modestly higher frequency of eosinophils in granulomatous lesions in Il13ra1 -/-mice ( Fig. 5b) , which was consistent with the higher IL-5 production in these mice (Fig. 4) . Nevertheless, despite their wild-type inflammatory response, the development of hepatic fibrosis in the Il13ra1 -/-mice was significantly lower at both the acute and chronic time points (Fig. 5c) . Notably, the attenuated fibrotic response was not attributed to differences in parasite burden (Supplementary Table 2 online).
To explore the mechanisms by which IL-13Ra1 regulates the pathogenesis of schistosomiasis, we isolated liver RNA at 9 and 12 weeks after infection and used real-time PCR to quantify the expression of genes associated with T H 2 responses (Fig. 6a) , alternative macrophage activation ( Fig. 6b ) and extracellular matrix deposition (Fig. 6c) . In agreement with the intracellular cytokine staining data, Il13ra1 -/-mice had much higher expression of transcripts encoding IL-13, IL-4 and IL-10; these findings confirmed the conclusion that the type II IL-4R functions as a negative regulator of T H 2 responses in vivo (Fig. 6a) . We also noted much greater abundance of transcripts encoding tumor necrosis factor and near ablation of expression of eotaxin 1 (Ccl11) mRNA in Il13ra1 -/-mice, which suggested that type II IL-4R signaling regulates several distinct cytokine signals in the liver.
However, in contrast to the influence of IL-13Ra1 deficiency on the T H 2 response, we found no evidence that IL-13Ra1 regulated the expression of genes that characterize AAMf development in vivo (Fig. 6b) , consistent with our in vitro functional studies with BMDMs (Fig. 2) . Indeed, expression of genes encoding the mannose receptor, YM1, FIZZ1, AMCase and inducible nitric oxide synthase were significantly higher in Il13ra1 +/+ and Il13ra1 -/-livers after infection. Thus, IL-13Ra1 is not critically involved in alternative macrophage activation in vivo.
Finally, we monitored the expression of several matrix-associated genes, including those encoding transforming growth factor-b1 (Tgfb1), matrix metalloproteinase 9 (Mmp9) and procollagen VI (Col6a1), which are all induced in the liver after S. mansoni infection 8, 23 . Consistent with the diminished fibrosis, Col6a1 expression was much lower in Il13ra1 -/-livers (Fig. 6c) . In contrast, expression of Tgfb1 and Mmp9 was much higher in Il13ra1 -/-livers, particularly in the chronically infected mice. Thus, activation of the profibrotic cytokine TGF-b1 by MMP9 could have contributed to the residual increase in fibrosis noted in the Il13ra1 -/-mice.
Because the construction of the Il13ra1 -/-mouse included an in-frame insertion of a lacZ reporter gene, we measured b-galactosidase activity as a surrogate of Il13ra1 expression. We detected b-galactosidase activity in the villi, muscularis mucosae and muscularis externa of the gut in naive mice ( Supplementary Fig. 3 online) . However, the pattern of b-galactosidase expression in the gut changed very little after S. mansoni infection. In contrast, we noted little b-galactosidase activity in the liver before infection, although when we viewed sections under high power, we detected modest staining along the epithelial lining of the biliary tracts ( Supplementary Fig. 3 ). Nevertheless, b-galactosidase expression was much higher in the liver after infection, with substantial staining concentrated in fibroblast-dense areas surrounding the granulomas.
Lower mortality in Il13ra1 -/-mice We did survival studies with the S. mansoni model to determine the consequences of type II IL-4R deficiency during a chronic T H 2-driven inflammatory response. We included mice lacking both IL-4 and IL-13 (doubleknockout mice) as controls, as published studies have shown that mice with deficiencies in both type I and type II IL-4R signaling pathways are highly susceptible to S. mansoni infection [24] [25] [26] [27] . As expected, by week 10, over 75% of the doubleknockout mice succumbed to infection (Fig. 7a) . In contrast, the wild-type group showed only 50% mortality by week 18. However, over 80% of the Il13ra1 -/-mice survived through week 22, demonstrating that the type II IL-4R was highly pathogenic during S. mansoni infection. The enhanced survival of the chronically infected Il13ra1 -/-mice was also associated with much less liver fibrosis, as determined by hydroxyproline assay (Fig. 7b) and by microscopy (Fig. 7c) . In addition, markers of hepatocellular Cytokine production by liver granuloma-associated lymphocytes after S. mansoni infection. Il13ra1 +/+ and Il13ra1 -/-mice were infected with 35 S. mansoni cercariae and were killed at 9 and 12 weeks after infection; leukocytes isolated from perfused livers were stimulated for 3 h with phorbol 12-myristate 13-acetate and ionomycin in the presence of brefeldin A, followed by cytokine-specific antibodies. The frequency of cytokine-producing CD4 + T cells was determined for viable cells, identified by forward-and side-scatter parameters. Each dot represents an individual mouse; horizontal bars in the midst of the dots indicate the mean for each group. *, P o 0.05; **, P o 0.01. Data are representative of three experiments, one on the BALB/c background and two on the C57BL/6 background, which yielded similar results.
damage and biliary obstruction (alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase) were also significantly lower in the serum of chronically infected Il13ra1 -/-mice (Fig. 7d) . (Fig. 8a) . However, despite showing stronger T H 2 responses, Il13ra1 -/-mice failed to expel the parasites, emphasizing the importance of the type II IL-4R in this process (Fig. 8b) .
IL-13Ra1 is required for allergic airway hyperreactivity Finally, we examined the function of the type II IL-4R in a mouse model of asthma 29 . Il13ra1 +/+ mice primed and challenged intratracheally with S. mansoni egg antigen (SEA), a strong T H 2 stimulus, developed robust T H 2 responses in the lungs, as shown by quantitative PCR analysis of cytokine gene expression (Fig. 9a) . However, as noted in the infection studies, Il13ra1 -/-mice developed enhanced lung T H 2 responses. Il13ra1 -/-mice showed no defect in induction of Arg1 expression (Fig. 9a) , a marker of alternative macrophage activation; this finding suggests that the type II IL-4R is not critical for the development of Arg1-expressing cells in the lung, in agreement with the S. mansoni infection studies (Fig. 6b) . Furthermore, analysis of bronchoalveolar lavage fluid suggested that IL-13Ra1 had little effect on the inflammatory response (Fig. 9b) , although close examination of lung histology indicated that there were fewer eosinophils and more macrophages in the lungs of Il13ra1 -/-mice (Fig. 9c) . Nevertheless, despite developing substantial inflammation and stronger T H 2 responses, Il13ra1 -/-mice showed little to no increase in the expression of several important asthma-associated genes, including Ccl11, Clca3 and Muc5ac (Fig. 9a) . IgE titers were also much lower in the serum of SEA-challenged Il13ra1 -/-mice (Fig. 9d) . Most notable, however, was the complete absence of airway hyperreactivity ( Fig. 9e ) and mucus hypersecretion (Fig. 9f,g ) in Il13ra1 -/-mice, which indicated that the type II IL-4R was critically required for the development of allergic airway disease. 32 . Finally, although IL-13 signals exclusively through the type II IL-4R complex, the remaining IL-4 response in IL-13-deficient mice can signal through both type 1 and type II IL-4 receptors 30 . Therefore, disrupting IL-13Ra1 expression has proven to be the best strategy for characterizing the unique functions of the type II IL-4R.
DISCUSSION
In vitro experiments with both hematopoietic (BMDM) and nonhematopoietic (primary fibroblast) cell types confirmed that Il13ra1 -/-mice were unresponsive to IL-13. Whereas published studies have suggested that IL-13 is critically involved in the development of CD4 + T H 2 cell responses in vivo 20, 33 , our experiments suggested the opposite. Indeed, Il13ra1 -/-mice developed stronger T H 2 responses in all three experimental disease models examined, suggesting that IL-13Ra1 'antagonizes' CD4 + T H 2 cell development in vivo. These results were somewhat unexpected, because IL-13 activity is abrogated in both IL-13-deficient and IL-13Ra1-deficient mice. However, disruption of Il13 diminished transcription of the closely linked Il4 gene 19 .
Therefore, IL-13-deficient mice are to some extent also deficient in IL-4. The lower production of IL-4 probably explains why CD4 + T H 2 cell development is impaired in IL-13-deficient mice. Our results have shown that type II IL-4R-dependent signaling suppressed T H 2 cytokine responses. Because type I and type II IL-4 receptors compete for IL-4, the absence of the type II IL-4R complex may yield more free IL-4 to bind the type I IL-4R expressed on T cells. This may explain why CD4 + T H 2 cell development is enhanced in the absence of IL-13Ra1. However, a quantitative trait locus in a region of 129 DNA closely linked to IL-13Ra1 might also contribute to this. IL-13 also activates human B cells, augments antibody production and regulates IgE antibody class switching 21, 34, 35 . Although mouse B cells were originally reported to be unresponsive to IL-13 (ref. 16) , it has been shown that IL-13 can enhance antibody production in mice by increasing B cell survival 17 . IL-13-transgenic mice are also capable of developing IgE responses in the absence of IL-4 (ref. 36). Because their T H 2 response remains intact, Il13ra1 -/-mice provide an ideal tool for investigating the function of type II IL-4R signaling in B cell development and antibody class switching in vivo. In general, our data indicated that the type II IL-4R had little to no influence on IgG production after infection. The only substantial difference noted in the Il13ra1 -/-mice was lower serum IgE titers in mice chronically infected with S. mansoni, a finding recapitulated in our asthma studies. These data suggest that antibody responses (except those of the IgE subclass) are regulated mainly by IL-4 operating through the type I IL-4R. IL-4 and IL-13 are also key inducers of AAMfs 11 , which are believed to regulate antiparasite immunity 37 , wound healing 11 , fibrosis 38 , asthma 39 , allergic inflammation 40 and several other T H 2 disorders 38 . Studies of mice with macrophage-specific IL-4Ra deficiency have confirmed that IL-4Ra is essential for AAMf development 26 . Our in vitro studies showed that IL-13 exclusively exploited the type II IL-4R to promote AAMf development, whereas IL-4 used both type I and type II IL-4 receptors. It has been shown that AAMfs are critical for survival during the acute period of S. mansoni infection (8-9 weeks) 41 . However, the specific contribution of the type I IL-4R versus the type II IL-4R in the development of this early protective response has remained unclear, as both signaling pathways are effectively 'knocked out' in LysMCre-Il4ra -/flox mice, which have deletion of IL-4R specifically in macrophages and neutrophils. Our results with Il13ra1 -/-mice indicated that the type I IL-4R is sufficient for granuloma formation and protection during S. mansoni infection, even after high-dose challenge with the parasite. Unexpectedly, even though type II IL-4R signaling can facilitate the development of AAMfs in vitro, the type II receptor was dispensable for AAMf development in vivo. Indeed, several phenotypic markers of AAMfs were highly induced in the livers of infected Il13ra1 +/+ and Il13ra1 -/-mice, which suggested that the type I IL-4R is sufficient for AAMf development in vivo.
In addition to regulating survival during S. mansoni infection, AAMfs have been postulated to regulate tissue fibrogenesis 42 and mediate protection against gastrointestinal nematode parasites 37 . Il13ra1 -/-mice were an ideal model with which to examine the function of IL-4-and IL-13-driven type II IL-4R-dependent signaling in the development of fibrosis and antihelminth immunity, as type I IL-4R signaling remained intact. Unexpectedly, although the S. mansoni-infected Il13ra1 -/-mice developed exacerbated T H 2 responses and AAMf development seemed normal by several criteria, liver fibrosis was considerably less in the absence of IL-13Ra1, which we confirmed by hydroxyproline assay, liver microscopy and quantitative RT-PCR analysis of several extracellular matrix-related genes. In addition, Il13ra1 -/-mice were also highly susceptible to N. brasilenisis infection, again despite developing strong T H 2 and AAMf responses. Thus, our data show that the type II IL-4R functions as the critical signaling mechanism for the development of fibrosis and antihelminth immunity. In addition, they suggest that the type I IL-4R and AAMfs are less important in these processes than hypothesized before. These observations suggest that fibroblasts and other type II IL-4R-expressing cells are probably the key regulators of fibrosis.
Whereas 'pan-IL-4R-defective' mice (Il4 -/-, Il4ra1 -/-and LysMCreIl4ra1 -/flox ) are highly susceptible to toxic death during S. mansoni infection 26, 27 , deletion of the type II IL-4R provided a long-lasting protective effect. Thus, these data demonstrate that the type I IL-4R is host protective, whereas the type II IL-4R serves a mainly pathogenic function during chronic schistosomiasis. Notably, although the profibrotic cytokine TGF-b1 has been suggested to be a mediator of IL-13-driven fibrosis 9,43 , we noted greater production of TGF-b1 and MMP9 but much less fibrosis in Il13ra1 -/-mice. Il13ra2 mRNA expression was also lower in Il13ra1 -/-mice, suggesting that their TGF-b1 response was independent of both IL-13Ra1-and IL-13Ra2-dependent signaling 9 . These findings suggest that the development of fibrosis in schistosomiasis is dependent on the type II IL-4R.
Although our in vivo studies indicated that the type II IL-4R was not critically involved in the expression of genes associated AAMfs, including Arg1, some genes were highly dependent on the type II signaling pathway, including Ccl11, Ccla3 and Muc5ac. These findings suggest that some IL-4-and IL-13-regulated genes are more dependent on type II IL-4R-mediated signaling than are others. Differences in the Il13ra1 expression of type I and type II IL-4 receptors on distinct cell populations (macrophages, epithelial cells and so on) may explain this variability. We also found that allergen-induced airway hyperreactivity and mucus production were almost completely dependent on the type II IL-4R. In these experiments, allergen-sensitized Il13ra1 -/-mice developed stronger T H 2 responses and upregulated Arg1 mRNA expression in tissues, as noted in our infection studies. However, airway hyperreactivity and mucus production were completely abrogated. Arginase 1 has been shown to be involved in asthma pathogenesis 39, 44 .
Our findings suggest that arginase 1 and the type I IL-4R are insufficient for the development of airway hyperreactivity and mucus hyperplasia and that additional factors induced by the type II IL-4R are required. In summary, our results suggest that the type II IL-4R seems to be involved in the activation of important mesenchymal cells such as fibroblasts and epithelial cells, which contribute to the development of chronic morbidity and mortality in schistosomiasis and in allergic asthma. A study has suggested that AAMfs are beneficial in the treatment of type 2 diabetes 45 . Thus, our findings suggest that for some chronic diseases, it may be more advantageous to target the pathogenic type II IL-4R while leaving the type I IL-4R (dominant AAMf-inducing) pathway intact.
METHODS
Generation of Il13ra1 -/-mice. VelociGene technology was used to generate the Il13ra1 -/-mice 10 ( Supplementary Fig. 1a ). Heterozygous female offspring were repeatedly backcrossed to the C57BL/6 and BALB/c backgrounds. Because the Il13ra1 gene is located on the X chromosome, all male offspring carry either the mutant (50%) or wild-type (50%) allele. DNA obtained from tail tissue was genotyped (primers, Supplementary Table 3 online). Unless otherwise specified, all experiments used male wild-type and mutant littermates at the N 8 backcross on the BALB/c background. Mice were housed in a specific pathogen-free animal facility at National Institute of Allergy and Infectious Diseases. All experimental protocols were approved by the animal care and use committee of the National Institute of Allergy and Infectious Diseases.
Parasites and experimental infections. Mice were infected percutaneously with about 35 S. mansoni cercariae as described 46 . Schistosome experiments used mice of generations N 4 -N 8 , with appropriate littermate controls of the same generation. Mice of these generations were indistinguishable in terms of each phenotype examined. N. brasiliensis larvae (L3) were prepared as described 47 . Wild-type and mutant littermates (N 8 ; C57BL/6 background) were inoculated by subcutaneous injection of 500 L3.
Hepatic leukocyte isolation. About 200 mg of granulomatous liver was disrupted into a single-cell suspension by being ground through a 100-mm nylon mesh. Leukocytes were separated on a 34% (vol/vol) Percoll gradient (350g for 20 min). After being washed twice in RPMI medium, liver leukocytes were treated for 2 min with 2 ml ACK (ammonium chloride-potassium bicarbonate) lysis buffer to lyse erythrocytes. Intracellular cytokine staining. Leukocytes isolated from granuloma or mesenteric lymph nodes were stimulated for 3 h with phorbol 12-myristate 13-acetate (10 ng/ml), ionomycin (1 mg/ml) and brefeldin A (10 mg/ml). Cells surfaces were stained with phycoerythrin-indodicarbocyanine-conjugated antibody to CD4 (anti-CD4; H129.19), were fixed for 20 min at 25 1C in 2% (wt/vol) formaldehyde, were made permeable for 30 min with 0.1% saponin buffer and were further stained with fluorescein isothiocyanateconjugated anti-IFN-g (XMG1.2) phycoerythrin-conjugated anti-IL-13 (C531; Centocor), Alexa Fluor 647-conjugated anti-IL-4 (11B11) and allophycocyanin-conjugated anti-IL-5 (TRFK5) before being analyzed on a FACSCalibur (Beckton Dickinson). Antibodies were from BD Pharmingen except where noted otherwise.
RNA isolation and real-time PCR. About 100 mg of liver tissue was preserved at -80 1C in 500 ml of RNAlater (Ambion). The sample was homogenized in 1 ml TRIzol reagent (Invitrogen) and total RNA was extracted and analyzed by real-time PCR as described 29 Enzyme-linked immunosorbent assay. Immulon 2HB plates (Thermo) were coated overnight with SEA (10 mg/ml in PBS). After plates were blocked with 5% (wt/vol) nonfat dry milk (Carnation), serum was added at various dilutions beginning with a 1:10 dilution. The following secondary antibodies (Southern Biotech) were used for the detection of the corresponding isotypes: anti-IgG1 (H143.225.8), anti-IgG2b (LO-MG2b), anti-IgG3 (LO-MG3), anti-IgA (11-44.2), anti-IgE (23G3) and anti-IgM (1B4B1). Total serum IgE was measured with capture antibody to mouse IgE (R35-72) and biotinylated detection antibody to mouse IgE (R35-118), with a recombinant IgE standard curve .
Fibrosis, histopathology and b-galactosidase staining. Tissue were fixed in Bouin-Hollande fixative and were embedded in paraffin for sectioning. Sizes of hepatic granulomas and composition of lung inflammation were determined on histological sections stained with Wright's Giemsa stain as described 29 . Hepatic collagen was measured as hydroxyproline after hydrolysis of 200 mg liver in 5 ml of 6 N HCl. Goblet cells were stained with Alcian blue-periodic acid Schiff and were assigned scores of 1 through 4, where '0' is no PAS + staining and '4' is the maximum staining noted. A published protocol was used for b-galactosidase staining 49 . The same person assigned scores for all histological features and had no knowledge of the experimental design.
Immunoblot. Tyrosine-phosphorylated STAT6 were measured by immunoblot as described 50 . After cytokine treatment, cells were washed three times with Dulbecco's PBS and whole-cell lysates were prepared. Total STAT6 protein was immunoprecipitated with rabbit anti-STAT6 (SC-621; Santa Cruz Biotechnology). Immunoprecipitated proteins were resolved by 8% SDS-PAGE (Invitrogen) and then were transferred to polyvinylidene difluoride membranes. Tyrosine-phosphorylated STAT6 or total STAT6 was visualized by enhanced chemiluminescence with rabbit antibody to STAT6 phosphorylated at Tyr641 (93645; Cell Signaling Technology) or rabbit anti-STAT6, respectively.
Macrophage and fibroblast cultures. These cultures are described in the Supplementary Methods online.
Arginase activity and nitrite assays. BMDMs or thioglycollate-elicited macrophages (day 4) were cultured in 48-well tissue culture plates and were stimulated with IL-4 or IL-13 (20 ng/ml). After being stimulated, cells were washed with PBS and were lysed with 0.1% (wt/vol) Triton X-100 containing protease inhibitor (Roche Diagnostics). Lysates were transferred to a 96-well PCR plate and were incubated for 10 min at 55 1C with 10 mM MnCl 2 and 50 mM Tris HCl, pH 7.5, for enzyme activation. Then, 25 ml lysate was removed and was added to 25 ml of 1 M arginine, pH 9.7, in a new PCR plate, followed by incubation for 20 h at 37 1C. A portion (5 ml) of each sample was added in duplicate to a 96-well enzyme-linked immunosorbent assay plate along with 5 ml of each standard, diluted in the same assay conditions, beginning with 100 mg/dl. The urea determination reagent from the BioAssay Systems Quantichrome Urea Assay Kit was used according to the manufacturer's protocol. The concentration of nitrite in culture supernatants was determined by spectrophotometry with the Griess reagent.
Allergic airway inflammation and hyperreactivity. Mice were primed and boosted by intraperitoneal injection of 10 mg SEA in PBS on days 0 and 7, respectively. On days 14, 16 and 18, SEA-primed mice were anesthetized with a ketamine-xylazine 'cocktail' and were challenged by intratracheal instillation of 10 mg of SEA in 30 ml PBS. Then, 24 h after the last challenge, the airway hyperreactivity of unrestrained mice in response to aerosolized methacholine (3-25 mg/ml in PBS; Sigma-Aldrich) was measured by noninvasive whole-body plethysmography (Buxco systems). Each dose of methacholine was aerosolized for 2 min, followed by 4 min of data collection during which enhanced-pause measurements were collected and averaged for the entire dose period. Mice
